In this webinar, we unlock the landscape of this promising space and delve into how this could shape the future of ADC drugs. Watch the recording now.
Webinar Leaders
House Speaker
Jia He
ADC Technical Lead
Beacon
Moderator
Eleni Taoula
Account Manager
Beacon
Speak with our team about Beacon ADC
What is Beacon ADC?
Beacon ADC is a manually curated database solution that includes clinical trial and drug records for preclinical, active, approved and discontinued:
- ADC (Antibody Drug Conjugates)
- Immunotoxins
- SMDCs (Small Molecule Drug Conjugates)
- Radioimmunoconjugates
- Ligand Conjugated Nanoparticles
- Liposomal Drug Conjugate and other comparable modalities
How Beacon ADC Works
Search the trial and drug landscape by linker, payload and target alongside 20 other search criteria including disease, line of therapy, biomarker, sponsor etc. Instantly extract the data points you need to conduct more complex analyses.
Our unique Milestones filter and visualization highlights past, present, and future drug development milestones including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely and exhaustive single-drug timeline allowing you to benchmark progress in the ADC space.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
